Agilent Technologies Introduces SureDesign, Simplifying the Creation of Custom SureSelect/HaloPlex DNA Sequencing Panels


SANTA CLARA, Calif., Oct. 8, 2012

Agilent Technologies Inc. (NYSE: A) today introduced SureDesign, a new online interface to help researchers create customized target-enrichment panels for next-generation sequencing.

With this new interface, researchers can quickly generate exceptionally flexible designs for high-performance, targeted resequencing, using Agilent's HaloPlex and SureSelect systems. Now, in just three simple steps, they can create custom sequencing panels tailored to their specific projects. Targeted resequencing of genes/genomic regions is a key step in detecting mutations associated with congenital disease.

"With SureDesign, users can take full advantage of the unmatched level of customization available with our market-leading HaloPlex and SureSelect products, creating high-coverage designs in a matter of minutes," said Kathleen Shelton, Agilent's senior marketing director for genomics.

SureDesign provides an intuitive design environment that gives researchers the flexibility they need to assemble customized panels for targeted resequencing. It also enables them to streamline entire projects by improving the ability to focus sequencing efforts on specific genomic regions. SureDesign's collaborative community-based online interface empowers users to work together across labs and geographic barriers to create new sequencing designs, share them with each other. Additionally, users can easily access, modify and merge existing gene panels.

Available immediately, SureDesign replaces Agilent's eArray for SureSelect DNA target enrichment and the HaloPlex Design Wizard. SureDesign supports all Agilent custom target-enrichment formats and applications, including SureSelect and HaloPlex. For more information, visit For online tutorials, visit

About Agilent in Genomics

Agilent Technologies Inc. is a global leader in target enrichment for next-generation sequencing and genomic microarrays. The Agilent SureSelect and HaloPlex Target Enrichment Systems enable researchers to easily choose which segments of a genome to sequence, avoiding the time and expense needed to sequence the entire genome. HaloPlex and its same-day sample-to-sequencer workflow is well suited for next-generation desktop sequencers, whereas SureSelect's ability to accurately capture whole exomes and whole methylomes in a single reaction pairs well with high-throughput next-generation sequencing systems. These are just two products arising from Agilent's expertise in synthesizing custom complex mixtures of long oligonucleotide gained in microarray manufacturing. Additional product lines built on this core technology include microarrays for genome-wide measurement of gene expression and for comparative genomics hybridization, as well as SureFISH, a highly specific and sensitive oligonucleotide fluorescent in situ hybridization product line. In addition to oligonucleotide-based products, Agilent offers a microfluidic bioanalyzer to measure sample quality, a target-enrichment tool to speed next-generation sequencing, and a full set of reagents, hardware, methods and bioinformatics software for genomic experiments.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,000 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at

# # #


Susan Berg
+1 408 553 7093